CHARM-Added研究PPT课件.pptVIP

CHARM Added: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Added Purpose To determine whether addition of the angiotensin II receptor blocker candesartan is beneficial in patients with chronic heart failure (CHF) who are taking angiotensin converting enzyme (ACE) inhibitors Reference McMurray JJV, ?stergren J, Swedberg K, et al. for the CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial